Agostoni, E., Rigamonti, A., 2012. Migraine and small vessel diseases. Neurol Sci. 33, S51–4.
Amin, F. M., et al., 2013. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: A cross-sectional study. Lancet Neurol. 12, 454–61.
Armstrong, A.E., Gillan, E., DiMario, F.J. Jr., 2014. SMART syndrome (stroke-like migraine attacks after radiation therapy) in adult and pediatric patients. J Child Neurol. 29, 336–41.
Attwell, D., et al., 2010. Glial and neuronal control of brain blood flow. Nature. 468, 232–43.
Bartleson, J.D., Swanson, J.W., Whisnant, J.P., 1981. A migrainous syndrome with cerebrospinal fluid pleocytosis. Neurology. 31, 1257–62.
Bashir, A., et al., 2013. Migraine and structural changes in the brain: A systematic review and meta-analysis. Neurology. 81, 1260–8.
Black, D.F., et al., 2006. SMART: Stroke-like migraine attacks after radiation therapy. Cephalalgia. 26, 1137–42.
Bradshaw, J., et al., 2011. Neurocognitive recovery in SMART syndrome: A case report. Cephalalgia. 31, 372–6.
Burke, M. J., et al., 2017. Unique CT perfusion imaging in a case of HaNDL: New insight into HaNDL pathophysiology and vasomotor principles of cortical spreading depression. Headache. 57, 129–34.
Caputi, L., et al., 2010. Microembolic air load during contrast-transcranial Doppler: A trigger for migraine with aura? Headache. 50, 1320–7.
Cavazos, J.E., et al., 1994. Sumatriptan-induced stroke in sagittal sinus thrombosis. Lancet. 343, 1105–6.
Chabriat, H., et al., 2009. CADASIL. Lancet Neurol. 8, 643–53.
Chang, C.L., Donaghy, M., Poulter, N., 1999. Migraine and stroke in young women: Case–control study. The World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. BMJ. 318, 13–8.
Davis, D., et al., 2013. Patent foramen ovale, ischemic stroke and migraine: Systematic review and stratified meta-analysis of association studies. Neuroepidemiology. 40, 56–67.
Debette, S., 2015. Comment: Tackling shared genetic underpinnings of migraine and ischemic stroke. Neurology. 84, 2143.
Dowson, A., et al., 2008. Migraine Intervention with StarFlex Technology (MIST) trial: A prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with StarFlex septal repair implant to resolve refractory migraine headache. Circulation. 117, 1397–404.
Dreier, J. P., 2011. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med. 17, 439–47.
Eising, E., et al., 2013. Pearls and pitfalls in genetic studies of migraine. Cephalalgia. 33, 614–25.
Emond, H., et al., 2009. Syndrome of transient headache and neurological deficits with CSF lymphocytosis (HaNDL) associated with recent human herpes virus-6 infection. Cephalalgia. 29, 487–91.
Etminan, M., et al., 2005. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 330, 63.
Friedenberg, S., Dodick, D. W., 2000. Migraine-associated seizure: A case of reversible MRI abnormalities and persistent nondominant hemisphere syndrome. Headache. 40, 487–90.
Fuentes, B., Diez-Tejedor, E., Frank, A., 1998. Syndrome of headache with neurological deficits and CSF lymphocytosis: A spreading depression mechanism? The role of SPECT. Headache. 38, 324.
Galimi, R., 2012. Migraine and ischemic stroke: Possible pathogenic relation. Recenti Prog Med. 103, 319–27.
Gomez-Aranda, F., et al., 1997. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain. 120, 1105–13.
Gormley, P., et al., 2016. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 48, 856–66.
Guillon, B., et al., 2007. Do extracellular-matrix-regulating enzymes play a role in cervical artery dissection? Cerebrovasc Dis. 23, 299–303.
Gursoy-Ozdemir, Y., et al., 2004. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 113, 1447–55.
Hadjikhani, N., et al., 2001. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 98, 4687–92.
Hall, G.C., et al., 2004. Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology. 62, 563–8.
Hamedani, A.G., et al., 2013. Migraine and white matter hyperintensities: The ARIC MRI study. Neurology. 81, 1308–13.
Kaderali, Z., Lamberti-Pasculli, M., Rutka, J.T., 2009. The changing epidemiology of paediatric brain tumours: A review from the Hospital for Sick Children. Childs Nerv Syst. 25, 787–93.
Kappler, J., Mohr, S., Steinmetz, H., 1997. Cerebral vasomotor changes in the transient syndrome of headache with neurologic deficits and CSF lymphocytosis (HaNDL). Headache. 37, 516–8.
Kerklaan, J.P., et al., 2011. SMART syndrome: A late reversible complication after radiation therapy for brain tumours. J Neurol. 258, 1098–104.
Kowa, H., et al., 2005. Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura. Neurosci Lett. 374, 129–31.
Kruit, M. C., et al., 2004. Migraine as a risk factor for subclinical brain lesions. JAMA. 291, 427–34.
Kruit, M. C., et al., 2005. Infarcts in the posterior circulation territory in migraine. The population-based MRI CAMERA study. Brain. 128, 2068–77.
Kruit, M. C., et al., 2006. Brain stem and cerebellar hyperintense lesions in migraine. Stroke. 37, 1109–12.
Kurth, T., Tzourio, C., 2009. Migraine and cerebral infarct-like lesions on MRI: An observation, not a disease. JAMA. 301, 2594–5.
Kurth, T., Diener, H.C., 2012. Migraine and stroke: Perspectives for stroke physicians. Stroke. 43, 3421–6.
Kurth, T., et al., 2009. Migraine frequency and risk of cardiovascular disease in women. Neurology. 73, 581–8.
Kurth, T., et al., 2010. Migraine and risk of haemorrhagic stroke in women: Prospective cohort study. BMJ. 341, c3659.
Kurth, T., et al., 2016. Migraine and risk of cardiovascular disease in women: Prospective cohort study. BMJ. 353, i2610.
Kurtuncu, M., et al., 2013. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL). Cephalalgia. 33, 123–9.
Larrosa-Campo, D., et al., 2012. Migraine as a vascular risk factor. Rev Neurol. 55, 349–58.
Laurell, K., et al., 2011. Migrainous infarction: A Nordic multicenter study. Eur J Neurol. 18, 1220–6.
Laurell, K., Lundstrom, E., 2012. Migrainous infarction: Aspects on risk factors and therapy. Curr Pain Headache Rep. 16, 255–60.
Lauritzen, M., 1994. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 117, 199–210.
Lee, M.J., Lee, C., Chung, C.S., 2016. The migraine–stroke connection. J Stroke. 18, 146–56.
Leira, R., et al., 2007. MMP-9 immunoreactivity in acute migraine. Headache. 47, 698–702.
MacClellan, L.R., et al., 2007. Probable migraine with visual aura and risk of ischemic stroke: The Stroke Prevention in Young Women study. Stroke. 38, 2438–45.
Malik, R., et al., 2015. Shared genetic basis for migraine and ischemic stroke: A genome-wide analysis of common variants. Neurology. 84, 2132–45.
Martin-Balbuena, S., Arpa-Gutierrez, F.J., 2007. Pseudomigraine with cerebrospinal fluid pleocytosis or syndrome of headache, temporary neurological deficit and cerebrospinal fluid. A historical review. Rev Neurol. 45, 624–30.
Mawet, J., Kurth, T., Ayata, C., 2015. Migraine and stroke: In search of shared mechanisms. Cephalalgia. 35, 165–81.
Meschia, J.F., et al., 2014. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 45, 3754–832.
Metso, T.M., et al., 2012. Migraine in cervical artery dissection and ischemic stroke patients. Neurology. 78, 1221–8.
Olesen, J., et al., 1993. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain. 116, 187–202.
Paemeleire, K., 2009. Brain lesions and cerebral functional impairment in migraine patients. J Neurol Sci. 283, 134–6.
Palm-Meinders, I.H., et al., 2012. Structural brain changes in migraine. JAMA. 308, 1889–97.
Partap, S., et al., 2006. Prolonged but reversible migraine-like episodes long after cranial irradiation. Neurology. 66, 1105–7.
Paterna, S., et al., 2000. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol. 43, 133–6.
Pettersen, J.A., et al., 2008. Global hemispheric CT hypoperfusion may differentiate headache with associated neurological deficits and lymphocytosis from acute stroke. Stroke. 39, 492–3.
Pezzini, A., et al., 2007. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke. 38, 3145–51.
Pezzini, A., et al., 2011. Predictors of migraine subtypes in young adults with ischemic stroke: The Italian project on stroke in young adults. Stroke. 42, 17–21.
Piilgaard, H., Lauritzen, M., 2009. Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex. J Cereb Blood Flow Metab. 29, 1517–27.
Pruitt, A., et al., 2006. Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation. Neurology. 67, 676–8.
Rigatelli, G., et al., 2011. May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression? Cardiovasc Revasc Med. 12, 217–9.
Ripa, P., et al., 2015. Spreading depolarization may link migraine, stroke, and other cardiovascular disease. Headache. 55, 180–2.
Rist, P.M., et al., 2011. Migraine, migraine aura, and cervical artery dissection: A systematic review and meta-analysis. Cephalalgia. 31, 886–96.
Sacco, S., et al., 2013. Migraine and hemorrhagic stroke: A meta-analysis. Stroke. 44, 3032–8.
Santos, E., et al., 2012. Spreading depolarizations in a case of migraine-related stroke. Cephalalgia. 32, 433–6.
Scher, A.I., et al., 2009. Migraine headache in middle age and late-life brain infarcts. JAMA. 301, 2563–70.
Schurks, M., et al., 2008. Interrelationships among the MTHFR 677 C>T polymorphism, migraine, and cardiovascular disease. Neurology. 71, 505–13.
Schurks, M., et al., 2009. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ. 339, b3914.
Schwedt, T.J., Demaerschalk, B.M., Dodick, D.W., 2008. Patent foramen ovale and migraine: A quantitative systematic review. Cephalalgia. 28, 531–40.
Shuper, A., et al., 1995. ‘Complicated migraine-like episodes’ in children following cranial irradiation and chemotherapy. Neurology. 45, 1837–40.
Spalice, A., et al., 2016. Stroke and migraine is there a possible comorbidity? Ital J Pediatr. 42, 41.
Spector, J.T., et al., 2010. Migraine headache and ischemic stroke risk: An updated meta-analysis. Am J Med. 123, 612–24.
Stovner, L., et al., 2007. The global burden of headache: A documentation of headache prevalence and disability worldwide. Cephalalgia. 27, 193–210.
Swartz, R.H., Kern, R.Z., 2004. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol. 61, 1366–8.
Takano, T., et al., 2007. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 10, 754–62.
Tana, C., et al., 2013. New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: Is gold all that glitters? J Headache Pain. 14, 9.
Tfelt-Hansen, P., et al., 2000. Ergotamine in the acute treatment of migraine: A review and European consensus. Brain. 123, 9–18.
Tietjen, G.E., 2009. Migraine as a systemic vasculopathy. Cephalalgia. 29, 987–96.
Vahedi, K., et al., 2004. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol. 61, 1237–40.
Vijayan, N., Peacock, J.H., 2000. Spinal cord infarction during use of zolmitriptan: A case report. Headache. 40, 57–60.
Wammes-van der Heijden, E.A., et al., 2006. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology. 67, 1128–34.
Wolf, M.E., et al., 2011. Clinical and MRI characteristics of acute migrainous infarction. Neurology. 76, 1911–7.
Wooltorton, E., 2003. Risk of stroke, gangrene from ergot drug interactions. CMAJ. 168, 1015.
Yuzawa, I., et al., 2012. Cortical spreading depression impairs oxygen delivery and metabolism in mice. J Cereb Blood Flow Metab. 32, 376–86.
Zhang, J.H., et al., 2004. Genetic predisposition to neurological symptoms in lacunar infarction. Cerebrovasc Dis. 17, 273–9.